Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT and SPIKEVAX X Injection.

RecruitingOBSERVATIONAL
Enrollment

4,206

Participants

Timeline

Start Date

March 10, 2023

Primary Completion Date

December 10, 2028

Study Completion Date

December 10, 2028

Conditions
SARS-CoV-2
Interventions
BIOLOGICAL

SPIKEVAX Bivalent

No study drug will be administered during this study as this is an observational study.

BIOLOGICAL

SPIKEVAX X

No study drug will be administered during this study as this is an observational study.

Trial Locations (24)

10108

RECRUITING

Nalee Hospital, Gimpo-si

10234

RECRUITING

COA ENT Clinic, Goyang-si

11404

RECRUITING

Hanyang Union Rehabilitation Medicine Clinic, Yangju

11456

RECRUITING

KimHyungjoo Clinic, Yangju

14250

RECRUITING

Joon Pediatric Clinic, Gwangmyeong

14483

RECRUITING

Hyundai Clinic, Bucheon-si

14614

RECRUITING

Ma Hak ki Family Medicine Clinic, Bucheon-si

14998

RECRUITING

Janghyeon Medicine Clinic, Siheung

21405

RECRUITING

Bupyeong Yonsei Medical Clinic, Incheon

22332

RECRUITING

Inha University Hospital, Incheon

26428

RECRUITING

Yonseimin Clinic, Wŏnju

48111

TERMINATED

Sinsegie ENT Clinic, Busan

54072

RECRUITING

Kium Children Hospital, Gunsan

61108

WITHDRAWN

Jeil Family Medicine Clinic, Gwangju

01684

RECRUITING

Woori Medical Clinic, Seoul

01851

RECRUITING

Yonsei Kids Pediatrics Clinic, Seoul

03912

RECRUITING

Star Pediatrics Clinic, Seoul

04032

RECRUITING

Seoul Bon Clinic, Seoul

05351

RECRUITING

Dr Cho's Family Medical Clinic, Seoul

05769

RECRUITING

Songpa Korea Neurosurgical Clinic, Seoul

06568

RECRUITING

GF Pediatrics Clinic, Seoul

06727

RECRUITING

Kim Il Joong Internal Medicine Clinic, Seoul

07327

RECRUITING

New Yonsei ENT Clinic, Seoul

08701

TERMINATED

Soo Orthopedics Clinic, Seoul

All Listed Sponsors
lead

ModernaTX, Inc.

INDUSTRY